Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2025-10-03 00:00:00 ET · period of report 2025-09-24 · accession 0001140361-25-037275 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2025-10-03 | 2025-09-24 | RCKT | Fong Peter | Dir | A - Grant | $0.00 | +53.3K | 53.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-09-24 | A | A | 23,333 | $0.00 | 23,333 | D | — | — | (F1) Represents restricted stock units ("RSUs") that convert to common stock on a one-for-one basis. The RSUs will vest in full on September 24, 2026. |
| 2 | Common | Common Stock | 2025-09-24 | A | A | 30,000 | $0.00 | 53,333 | D | — | — | (F2) Represents RSUs that will vest in equal monthly installments over a three-year period following September 23, 2025. |